C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.07 AUD 0.47% Market Closed
Market Cap: 118.9m AUD

Intrinsic Value

The intrinsic value of one CYC stock under the Base Case scenario is 3.27 AUD. Compared to the current market price of 1.07 AUD, Cyclopharm Ltd is Undervalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CYC Intrinsic Value
3.27 AUD
Undervaluation 67%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Cyclopharm Ltd

CYC
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CYC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Cyclopharm Ltd
ASX:CYC
AU
Health Care
Market Cap
118.9m AUD
IPO
Jan 18, 2007
AU
Health Care
Market Cap
118.9m AUD
IPO
Jan 18, 2007
Price
AU$false
EPS
AU$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CYC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cyclopharm Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cyclopharm Ltd

Current Assets 42.4m
Cash & Short-Term Investments 20.6m
Receivables 7.7m
Other Current Assets 14.2m
Non-Current Assets 19.7m
PP&E 13.1m
Intangibles 5.9m
Other Non-Current Assets 745.6k
Efficiency

Free Cash Flow Analysis
Cyclopharm Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cyclopharm Ltd

Revenue
27.6m AUD
Cost of Revenue
-9.6m AUD
Gross Profit
17.9m AUD
Operating Expenses
-32.4m AUD
Operating Income
-14.5m AUD
Other Expenses
1.3m AUD
Net Income
-13.2m AUD
Fundamental Scores

CYC Profitability Score
Profitability Due Diligence

Cyclopharm Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
24/100
Profitability
Score

Cyclopharm Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

CYC Solvency Score
Solvency Due Diligence

Cyclopharm Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Low D/E
91/100
Solvency
Score

Cyclopharm Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CYC Price Targets Summary
Cyclopharm Ltd

Wall Street analysts forecast CYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYC is 2.75 AUD with a low forecast of 2.73 AUD and a high forecast of 2.84 AUD.

Lowest
Price Target
2.73 AUD
155% Upside
Average
Price Target
2.75 AUD
157% Upside
Highest
Price Target
2.84 AUD
165% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CYC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CYC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CYC stock?

The intrinsic value of one CYC stock under the Base Case scenario is 3.27 AUD.

Is CYC stock undervalued or overvalued?

Compared to the current market price of 1.07 AUD, Cyclopharm Ltd is Undervalued by 67%.

Back to Top